Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Maia Biotechnology, Inc. (MAIA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 10,950,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   MAIA Biotechnology is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. Co.'s primary product candidate, 6-thio-dG or 6-thio-2'-deoxyguanosine (THIO), is a telomere-targeting agent in clinical development to evaluate its activity in non-small cell lung cancer (NSCLC). THIO is being developed as a second- or later line of treatment for NSCLC for patients that have progressed beyond the standard-of-care regimen of existing checkpoint inhibitors. Co.'s pipeline includes THIO-102, which is targeting colorectal cancer and THIO-103, which is targeting basket study.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 619,888 619,888 619,888 1,201,412
Total Buy Value $869,025 $869,025 $869,025 $3,108,759
Total People Bought 5 5 5 10
Total Buy Transactions 7 7 7 97
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 111
  Page 5 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Guerrero Ramiro Director   –       •      –    2022-07-28 4 B $4.00 $36,000 D/D 9,000 268,382 2.39     -
   Obrocea Mihail Chief Medical OfficerOfficer   •       –      –    2022-07-27 3 IO $0.00 $0 D/D 0 26,100     -
   Chaouki Steven M Director   –       •      –    2022-07-27 3 IO $0.00 $0 D/D 0 41,250     -
   Vitoc Vlad Chief Executive OfficerOfficer   •       •       •   2022-07-27 3 IO $0.00 $0 I/I 0 200,000     -
   Vitoc Vlad Chief Executive OfficerOfficer   •       •       •   2022-07-27 3 IO $0.00 $0 D/D 0 783,121     -
   Gryaznov Sergei Chief Scientific OfficerOffice   •       –      –    2022-07-27 3 IO $0.00 $0 D/D 0 21,511     -
   Vlad Laurentiu Director   –       •      –    2022-07-27 3 IO $0.00 $0 D/D 0 371,933     -
   Luput Cristian Director   –       •      –    2022-07-27 3 IO $0.00 $0 D/D 0 277,568     -
   Louie Ngar Yee Director   –       •       •   2022-07-27 3 IO $0.00 $0 D/D 0 908,584     -
   Smith Stan Director   –       •      –    2022-07-27 3 IO $0.00 $0 I/I 0 296,128     -
   Guerrero Ramiro Director   –       •      –    2022-07-27 3 IO $0.00 $0 D/D 0 259,382     -

  111 Records found
  1  2  3  4  5    
  Page 5 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed